| Literature DB >> 2184735 |
Abstract
The anemia of chronic renal failure can now be effectively treated with recombinant human erythropoietin when given in adequate doses. This hormone replacement therapy is associated with significant clinical benefits but it requires adequate iron stores for maximal effectiveness, it may result in elevation in diastolic blood pressure, and the response may be blunted by the presence of infection or inflammation.Entities:
Mesh：
Substances：
Year: 1990 PMID： 2184735 DOI： 10.1146/annurev.me.41.020190.002025
Source DB: PubMed Journal: Annu Rev Med ISSN： 0066-4219 Impact factor: 13.739